← Leaderboards
Yoshitake Cho
University Of California, San Diego
$1,659,979
Attributed
$3,319,958
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $987.7K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,319,958 · 2
By mechanism
R01$3,319,958 · 2
Top collaborators
- Robert Scott Ross4 shared
- Stephan Lange3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Stephan Lange$4,311,736
- Robert Scott Ross$18,254,836
- Neil C Chi$38,657,925
- Carolina Makowski$409,790
- Xi Fang$5,655,788
Others in their field
Other Emerging Leaders on “Novel Therapeutics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Novel TherapeuticsPressureMediatingMortalityPathway InteractionsPlayHeart MetabolismKnock-OutMetabolismMolecularOverexpressionBiogenesisPhysiologicalPhysiologyHeartHeart FailureHemodynamicsCardiacCardiac MyocytesMetabolicMetabolomicsMitochondriaAnimal ModelProteins
Grant awards (7)
The role of obscurin and Obsl1 as key determinants for diastolic function$564,661
R01 · FY2024 · HL · contact PI
The role of obscurin and Obsl1 as key determinants for diastolic function$584,516
R01 · FY2023 · HL · contact PI
PERM in Cardiac Function$395,000
R01 · FY2023 · HL
The role of obscurin and Obsl1 as key determinants for diastolic function$592,656
R01 · FY2022 · HL · contact PI
PERM in Cardiac Function$395,000
R01 · FY2022 · HL
PERM in Cardiac Function$394,375
R01 · FY2021 · HL
PERM in Cardiac Function$393,750
R01 · FY2020 · HL